LB780 Randomized, Blind, Placebo-Controlled Clinical Trial on the Clinical Efficacy of Oclacitinib, an Oral Janus Kinase Inhibitor, in a Canine Model of Spontaneously Occurring Atopic Dermatitis

Journal of Investigative Dermatology - United Kingdom
doi 10.1016/j.jid.2016.05.030
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV


Related search